These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor. Couturier A, Rey PA, Erginay A, Lavia C, Bonnin S, Dupas B, Gaudric A, Tadayoni R. Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483 [Abstract] [Full Text] [Related]
23. Linking Retinal Microvasculature Features With Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography. Bhanushali D, Anegondi N, Gadde SG, Srinivasan P, Chidambara L, Yadav NK, Sinha Roy A. Invest Ophthalmol Vis Sci; 2016 Jul 01; 57(9):OCT519-25. PubMed ID: 27472275 [Abstract] [Full Text] [Related]
26. The diagnostic accuracy of an intelligent and automated fundus disease image assessment system with lesion quantitative function (SmartEye) in diabetic patients. Xu Y, Wang Y, Liu B, Tang L, Lv L, Ke X, Ling S, Lu L, Zou H. BMC Ophthalmol; 2019 Aug 14; 19(1):184. PubMed ID: 31412800 [Abstract] [Full Text] [Related]
27. Distribution of Diabetic Neovascularization on Ultra-Widefield Fluorescein Angiography and on Simulated Widefield OCT Angiography. Russell JF, Flynn HW, Sridhar J, Townsend JH, Shi Y, Fan KC, Scott NL, Hinkle JW, Lyu C, Gregori G, Russell SR, Rosenfeld PJ. Am J Ophthalmol; 2019 Nov 14; 207():110-120. PubMed ID: 31194952 [Abstract] [Full Text] [Related]
28. EVALUATION OF MULTISPECTRAL IMAGING IN DIAGNOSING DIABETIC RETINOPATHY. Li L, Zhang P, Liu H, Liu YH, Gao L. Retina; 2019 Sep 14; 39(9):1701-1709. PubMed ID: 29901495 [Abstract] [Full Text] [Related]
29. Diabetic retinopathy and ultrawide field imaging. Ashraf M, Shokrollahi S, Salongcay RP, Aiello LP, Silva PS. Semin Ophthalmol; 2020 Jan 02; 35(1):56-65. PubMed ID: 32167854 [Abstract] [Full Text] [Related]
30. Changes in choroidal thickness in patients with diabetic retinopathy. Ohara Z, Tabuchi H, Nakakura S, Yoshizumi Y, Sumino H, Maeda Y, Kiuchi Y. Int Ophthalmol; 2018 Feb 02; 38(1):279-286. PubMed ID: 28194551 [Abstract] [Full Text] [Related]
31. Macular Capillary Perfusion in Chinese Patients With Diabetic Retinopathy Obtained With Optical Coherence Tomography Angiography. Yang D, Cao D, Huang Z, Xie J, Meng Q, Dong X, Hu Y, Zeng Y, Zhang L. Ophthalmic Surg Lasers Imaging Retina; 2019 Apr 01; 50(4):e88-e95. PubMed ID: 30998251 [Abstract] [Full Text] [Related]
32. Optical coherence tomography angiography analysis of the choriocapillary layer in treatment-naïve diabetic eyes. Yang J, Wang E, Zhao X, Xia S, Yuan M, Chen H, Zhang X, Chen Y. Graefes Arch Clin Exp Ophthalmol; 2019 Jul 01; 257(7):1393-1399. PubMed ID: 31089870 [Abstract] [Full Text] [Related]
34. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH. Invest Ophthalmol Vis Sci; 2013 May 09; 54(5):3378-84. PubMed ID: 23611988 [Abstract] [Full Text] [Related]
35. Distribution of Nonperfusion and Neovascularization on Ultrawide-Field Fluorescein Angiography in Proliferative Diabetic Retinopathy (RECOVERY Study): Report 1. Fan W, Nittala MG, Velaga SB, Hirano T, Wykoff CC, Ip M, Lampen SIR, van Hemert J, Fleming A, Verhoek M, Sadda SR. Am J Ophthalmol; 2019 Oct 09; 206():154-160. PubMed ID: 31078541 [Abstract] [Full Text] [Related]
36. The prevalence of diabetic retinopathy in Trang province determined by retinal photography and comprehensive eye examination. Supapluksakul S, Ruamviboonsuk P, Chaowakul W. J Med Assoc Thai; 2008 May 09; 91(5):716-22. PubMed ID: 18672638 [Abstract] [Full Text] [Related]
37. Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions. Wubben TJ, Johnson MW, Anti-VEGF Treatment Interruption Study GroupDepartment of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.. Am J Ophthalmol; 2019 Aug 09; 204():13-18. PubMed ID: 30878488 [Abstract] [Full Text] [Related]
38. NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY: RECOVERY Study. Fan W, Nittala MG, Wykoff CC, Brown DM, Uji A, Hemert JV, Fleming A, Robertson G, Sadda SR, Ip M. Retina; 2022 Mar 01; 42(3):426-433. PubMed ID: 34803132 [Abstract] [Full Text] [Related]
39. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial. Scott IU, Jackson GR, Quillen DA, Larsen M, Klein R, Liao J, Holfort S, Munch IC, Gardner TW. JAMA Ophthalmol; 2014 May 01; 132(5):535-43. PubMed ID: 24604308 [Abstract] [Full Text] [Related]
40. Hemorrhage and/or Microaneurysm Severity and Count in Ultrawide Field Images and Early Treatment Diabetic Retinopathy Study Photography. Silva PS, El-Rami H, Barham R, Gupta A, Fleming A, van Hemert J, Cavallerano JD, Sun JK, Aiello LP. Ophthalmology; 2017 Jul 01; 124(7):970-976. PubMed ID: 28336057 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]